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Dendritic cells (DCs) are antigen-presenting cells (APCs) capable of capturing haptens and
to process and present them to T lymphocytes. In order to sensitize T cells for contact
hypersensitivity (CHS), skin DCs suffer a maturation process with modifications on their
surface molecules. The aim of this work was to evaluate changes induced by two contact
sensitizers, 2,4-dinitrofluorobenzene (DNFB) and nickel sulfate (NiSO4), and a non-sensi-
tizer 2,4-dichloronitrobenzene (DCNB), on the protein levels of two activation markers,
CD40 and IL-12 receptor (IL-12R), in a mouse skin dendritic cell line (FSDC). The
expression of CD40 and IL-12R proteins was evaluated by western blot assay and direct
immunofluorescence microscopy. The results showed that CD40 and IL-12R expression
increased significantly after cell exposure to NiSO4 and DNFB, although DNFB exhibited a
stronger activity. There was no effect with DCNB. The epidermal cytokine granulocyte–
macrophage colony-stimulating factor (GM-CSF), also used in the experiments, slightly
increased the expression of both CD40 and IL-12R and when tested together with the
sensitizers the effect was partially additive. The results suggest that the sensitizers DNFB
and NiSO4 are directly involved on the changes of the surface markers CD40 and IL-12R in
skin DCs, during the sensitization phase of CHS, and this effect may be enhanced by GM-
CSF. In contrast, no effect was observed with DCNB.
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INTRODUCTION
Contact hypersensitivity (CHS) is a common inflammatory skin disease that occurs
as a consequence of increasing exposure to exogenous chemicals. It is a dendritic
cell-dependent, T cell-derived and cytokine-mediated skin inflammation (Enk, 1997;
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Watanabe et al., 2002). Langerhans cells (LCs) and keratinocytes are epidermal cells
that produce, constitutively or upon exogenous stimulation, a wide range of cyto-
kines (Kimber et al., 1995). These cytokines interact with appropriate receptors
expressed by LCs becoming crucial in the sensitization phase and in initiation of the
CHS (Watanabe et al., 2002).
LCs and other skin dendritic cells (DCs) are antigen presenting cells (APCs) that
play an important role in determining the cutaneous response to small chemicals
applied at the skin surface (Enk, 1997; Watanabe et al., 2002). These cells capture the
small molecular weight exogenous chemical (the hapten) by phagocytosis or by
pynocytosis, process it into a small hapten-modified peptide and combine this
allergen with a MHC molecule (Lipscomb and Masten, 2002). At this stage skin DCs
are very efficient in the uptake and processing of the antigens but poor stimulators of
primary T cell responses and, in the skin they would not find naı¨ve T cells for
priming. Therefore, they undergo maturation to become potent APCs and migrate to
the skin draining lymph nodes searching the appropriate naı¨ve T cells for sensiti-
zation (Girolomoni et al., 1995; Pieri et al., 2001; Satthaporn and Eremin, 2001).
The migration and maturation process of skin DCs involves profound changes
on the molecules that are expressed at their cell surface (Banchereau and Steinman,
1998), namely MHC class II (Herouet et al., 2000) and costimulatory molecules
(Coutant KD et al., 1999; Tuschl and Kovac, 2001), and on those secreted to the
extracellular milieu, including cytokines (Pichowski et al., 2000; De Smedt et al.,
2001) and metalloproteinases (Ratzinger et al., 2002).
In vitro studies, using whole human skin models, cultures of DCs derived from
circulating CD34+ cells or immortalized animal skin dendritic cells (Girolomoni
et al., 1995; Herouet et al., 2000; Tuschl et al 2000; De Smedt et al., 2001), have shown
a direct effect of some sensitizing chemicals, namely nickel, chromium, 2,4-dinitro-
chlorobenzene (DNCB), 2,4-dinitrofluorobenzene (DNFB) and 2,4,6-trinitrobenzene
sulfonic acid (TNBS), on the phenotypic and functional characteristics of DCs. They
upregulate DC expression of MHC class II and costimulatory molecules, namely
CD54, CD86, CD40, CD83 (Coutant et al., 1999; Herouet et al., 2000; De Smedt
et al., 2001; Tuschl and Kovac, 2001). Some reports indicate that sensitizing chemicals
may increase IL-1b and IL-12 secretion by DC cells although this is still a matter of
debate, since these responses were not always observed (Coutant et al., 1999; Aiba
et al., 2000; Pichowski et al., 2000; De Smedt et al., 2001; Tuschl and Kovac, 2001).
In this work, using a mouse fetal skin dendritic cell line (FSDC), we studied the
changes in the expression of membrane-associated receptors induced by chemicals
with different skin sensitizing properties, alone or in the presence of GM-CSF. GM-
CSF is one of the epidermal cytokines produced by keratinocytes after epidermal
application of skin sensitizers, being responsible for DC maturation (Kimber et al.,
1995; Pieri et al., 2001). The present work showed that nickel sulfate (NiSO4), the
most prevalent allergen in the human population, and DNFB, a potent experimental
sensitizer, upregulated DC expression of the CD40 protein and of the IL-12 receptor
(IL-12R). In contrast 2,4-dichloronitrobenzene (DCNB), an analogous of DNFB
which is considered a non-sensitizer (Becker et al., 1994), did not exhibit these effects.
The epidermal cytokine GM-CSF, which induces the maturation of FSDC (Kimber
et al., 1995; Jonuleit et al., 1996), also slightly increased CD40 and IL-12R expres-
sion, and this effect was additive with the response to the sensitizers.
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MATERIALS AND METHODS
Materials
DNFB was purchased from Sigma–Aldrich Quı´mica (Madrid, Spain). DCNB
and NiSO4 were from Sigma Chemical Co (St. Louis, MO, USA). The mouse re-
combinant GM-CSF was from R & D systems (Minneapolis, MN, USA). The rabbit
anti-mouse CD40 immunoglobulin and the rabbit anti-human antibody to IL-12
receptor beta 1 subunit (IL-12Rb1) were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). The mouse monoclonal antibody against actin and the protease
inhibitor cocktail were from Roche (Carnaxide, Portugal). Fetal calf serum was from
Biochrom KG (Berlin, Germany) and trypsin from Invitrogen (Paisley, UK). The
fluorescein isothiocyanate (FITC)-conjugated swine anti-rabbit immunoglobulin and
the swine serum were from DAKO (Copenhagen, Denmark). The mounting medium
for fluorescence, Vectashield, was obtained from Vector Laboratories, Inc. (Bur-
lingame, CA, U.S.A.). The ECL western blotting analysis system, the horseradish
peroxidase-conjugated donkey anti-rabbit immunoglobulin and the X-ray films were
from Amersham Biosciences (Carnaxide, Portugal). The horseradish peroxidase-
conjugated goat anti-mouse immunoglobulin was from Pierce (Illinois, USA). Tri-
ton X 100 and paraformaldehyde were from Merck (Lisboa, Portugal). All other
reagents were from Sigma Chemical Co (St. Louis, MO, USA).
Cell culture
The fetal mouse skin dendritic cell line FSDC, kindly supplied by Dr. G.
Girolomoni (Laboratory of Immunology, Instituto Dermopatico dell’Imacolata,
IRCCS, Rome, Italy), is a skin dendritic cell precursor with antigen presenting
capacity (Girolomoni et al., 1995). The cells were cultured in endotoxin free Iscove’s
Modified Dulbecco’s Medium (IMDM), supplemented with 10% (v/v) fetal calf
serum, 1% (w/v) glutamine, 3.02 g/l sodium bicarbonate, 100 lg/ml streptomycin
and 100 U/ml penicillin. For western blot analysis, FSDC were plated at 2 · 106
cells/well, in six-well culture plates, whereas for immunofluorescence analysis, FSDC
cells were grown on a Lab-Tek chamber slide with cover (0.2 · 106 cells/slide).
The effect of DNFB and NiSO4 on the expression of CD40 and IL-12R in
FSDC was determined by western blot and immunocytochemistry, after incubating
the cells with the compounds for 24 hr. The concentrations of DNFB (1 lg/ml) and
NiSO4 (50 lg/ml) used were those that produced maximal effect and no toxicity
(data not shown), as evaluated by the reduction of the tetrazolium bromide salt,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) (Mosmann,
1983).
NiSO4 was dissolved in culture medium. DNFB and DCNB were dissolved in
DMSO in a stock solution (10 mg/ml). Before incubation of the cells with these
compounds (DNFB and DCNB) the stock solution was diluted in sterile PBS
(10 ·) and the final concentrations of DNFB and DCNB were further diluted in the
culture medium containing the FSDC cells (1000 ·). Therefore, the concentration
of DMSO incubated with cells never exceeded 0.01%. Under these experimental
conditions the assay of cellular MTT reduction (a viability assay) in the presence
of this concentration of DMSO revealed no toxic effect and this concentration of
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DMSO alone was without effect on CD40 and IL-12R expression (data not
shown).
Western blot analysis
Total cell lysates were obtained after harvesting the cells in a sonication buffer
containing 0.32 M sucrose, 10 mM Tris–HCl (pH 7.5), 1 mM ethylene-diaminetet-
raacetic acid, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonylfluoride and the
protease inhibitor cocktail. Then, the lysates were incubated on ice for 30 min and
sonicated to disrupt the cells. Protein concentration was determined using the bi-
cinchoninic acid method.
In brief, protein samples were denatured and separated on a 10% (v/v) SDS-
PAGE, and transferred to a PVDF membrane. The membrane was blocked with 5%
(w/v) dry milk in Tris–buffered saline with 0.1% (v/v) Tween 20, for 1 hr. The levels
of CD40 and IL-12Rb1 proteins were detected using a rabbit anti-mouse CD40
(1:500) and a rabbit anti-human IL-12Rb1 (1:500) antibody, for 1 hr, followed by
incubation with a horseradish peroxidase-conjugated donkey anti-rabbit antibody
(1:5000). The immunocomplexes were visualized by the ECL chemiluminescence
method. To demonstrate equivalent protein loading the membranes were stripped
and reprobed with an anti-actin antibody (1:10000), followed by incubation with a
horseradish peroxidase-conjugated goat anti-mouse immunoglobulin (1:25000).
Immunofluorescence microscopy (immunocytochemistry)
After incubation in the absence or in the presence of the appropriate stimuli,
as indicated in Figs. 2c and 3c, the cells were washed with PBS and fixed with PBS
containing 4% (w/v) sucrose and 4% (w/v) paraformaldehyde, for 15 min. FSDC
were then permeabilized in PBS containing 1% (v/v) Triton X 100, for 10 min.
Non-specific binding was blocked by incubation of the cells with PBS supple-
mented with normal swine serum (1:20) and 0.5% (w/v) BSA–PBS, for 45 min, at
room temperature. Cells were then incubated with a rabbit anti-mouse CD40
immunoglobulin (1:50) or with a rabbit anti-human IL-12Rb1 antibody (1:50), for
90 min at room temperature. After rinsing with PBS, the cells were incubated with
FITC-conjugated swine anti-rabbit immunoglobulin (1:40) in 0.5% BSA–PBS, for
45 min. The cells were rinsed again and mounted with the mounting medium for
fluorescence, Vectashield. Cells labeled with FITC-anti CD40 or with FITC-anti
IL-12Rb1 antibodies were photographed on a Zeiss Axiovert 200 microscope.
Control experiments consisted of processing the same preparations as described,
except for the omission of the primary antibody, and resulted in no specific
staining.
Data analysis
Results are presented as mean ± SEM of the indicated number of experiments.
Mean values were compared using one-way ANOVA and the Bonferroni’s multiple
comparison test. The significance level was *p < 0.05, **p < 0.01 and
***p < 0.001.
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RESULTS
Effect of NiSO4, DNFB and DCNB on CD40 expression in FSDC
Stimulation of the cells with NiSO4 (50 lg/ml) or DNFB (1 lg/ml), for 24 hr,
increased significantly the expression of CD40, by 32 and 50%, respectively (Fig. 1a,
lanes 3 and 4) as demonstrated by western blot. In order to determine how FSDC
maturation affects the expression of CD40 induced by sensitizers, the cells were pre-
incubated with GM-CSF (100ng/ml), for 24 hr, before stimulation with NiSO4 or
DNFB. GM-CSF was previously shown to induce the differentiation and maturation
of DCs progenitors (Kimber et al., 1995; Jonuleit et al., 1996; Banchereau and
Steinman, 1998) and, in particular, of this cell line (Girolomoni et al., 1995; Pieri
Fig. 1. Effect of GM-CSF on NiSO4- and DNFB-induced CD40 protein expression. (a) Western blot
analysis of CD40 protein. FSDC cells (2 · 106 cells) were incubated in culture medium in the absence
(control, lane 1) or in the presence of GM-CSF (100 ng/ml, lane 2), DNFB (1 lg/ml, lane 3) or NiSO4
(50 lg/ml, lane 4). Where indicated, the cells were stimulated with GM-CSF in the presence of DNFB
(1 lg/ml, lane 5) or NiSO4 (50 lg/ml, lane 6). Total cell extracts were electrophoresed through SDS-PAGE
and subjected to western blot analysis using an anti-CD40 antibody, as described in ‘‘Materials and
Methods’’. The blot shown is representative of three blots yielding similar results. The blot was digitally
generated using a HP ScanJet 5p and processed in the Adobe Photoshop 7.0 program. (b) The bands were
quantified with an image analyser. The values are means ± SEM from three independent experiments,
where *p < 0.05, **p < 0.01 and ***p < 0.001, as determined by one-way ANOVA with Bonferroni?s
multiple comparison test. (c) Immunofluorescence analysis of CD40 protein. FSDC cells (0.2 · 106 cells)
were incubated on a Lab Tek chamber with cover, under the same conditions as described in A. Immu-
nostaining was performed as described in ‘‘Materials and Methods’’. Immunorreactivity means CD40
protein expression (% of control). Scale bars = 50 lm.
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et al., 2001). As shown in Fig. 1a and b, incubation of FSDC cells with GM-CSF, for
48 hr, increased the expression of CD40 by 23%, but this effect did not reach sta-
tistical significance (Fig. 1a, lane 2). However, when FSDC cells were incubated with
NiSO4 (50 lg/ml) or DNFB (1 lg/ml), for 24 hr, together with GM-CSF, after a
24 hr pre-incubation with the cytokine, the increase in the expression of CD40 was
slightly higher but not statistically different from that observed in the presence of the
sensitizers alone (58 and 70%, respectively) (Fig. 1a, lanes 5 and 6). Interestingly, the
small effect of GM-CSF on the expression of CD40 appears to be additive with the
response to the sensitizers. When the cells were incubated with the non-sensitizer
DCNB the observed effect was not different from the control (Fig. 1a, lane 7).
In Fig. 1c, immunofluorescence microscopy experiments performed under the
same experimental conditions confirmed all these results, demonstrating an upreg-
ulation of CD40 expression induced by the sensitizers NiSO4 and DNFB, and a
slightly higher increase in the expression of the protein in cells pre-incubated with
GM-CSF. Immunofluorescence also confirmed that the non-sensitizer DCNB had
no significant effect on this model.
Effect of NiSO4, DNFB and DCNB on IL-12R expression in FSDC
The effect of NiSO4, DNFB and DCNB on the expression of IL-12R in FSDC
cells is summarized in Fig. 2a and b. In FSDC cells incubated with NiSO4 (50 lg/ml)
or with DNFB (1 lg/ml), for 24 hr, the expression of IL-12R was increased by 45 and
72%, respectively, when compared with control cells, i.e., cells incubated with culture
medium (Fig. 2a, lanes 1, 4 and 5). DCNB had no effect on this model (Fig. 2a, lane
7). In order to determine how FSDC maturation affects the expression of the IL-12R
induced by sensitizers, the cells were pre-incubated with GM-CSF (100 ng/ml), for
24 hr, before stimulation for an additional 24 hr with NiSO4 or DNFB, together with
the cytokine. When the cells were incubated only with GM-CSF, for 48 hr, we ob-
served a non-statistically significant increase of IL-12R expression of 23% (Fig 2a,
lane 2). When FSDC cells were incubated with the sensitizers NiSO4 (50 lg/ml) or
DNFB (1 lg/ml), for 24 hr, together with GM-CSF, after a 24 hr pre-incubation with
the cytokine, the increase in IL-12R expression (66 and 90%, respectively) was higher
but not statistically different from that observed in cells stimulated only by the sen-
sitizers (Fig. 2a, lanes 3 and 6). As observed for the expression of CD40, the small
effect of GM-CSF on IL-12R expression was additive with the response to the sen-
sitizers. When the cells were incubated with the non-sensitizer DCNB the observed
effect was not different from the control (Fig. 2a, lane 7).
In Fig. 2c, immunofluorescence microscopy confirmed all of these results,
demonstrating an upregulation of IL-12R expression induced by the sensitizers
NiSO4 and DNFB in cells pre-incubated or not with GM-CSF. The immunofluo-
rescence also confirmed that the non-sensitizer DCNB did not affect the expression
of the IL-12R.
DISCUSSION
FSDC is a fetal mouse skin derived dendritic cell line, which represents a model
of a skin DC precursor. These cells are sensitive to and require cytokine activation to
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become functionally efficient APCs (Girolomoni et al., 1995). We have previously
shown that FSDC are sensitive to the epidermal cytokine GM-CSF (Cruz et al.,
2001; Vital et al., 2003), which is involved on DC differentiation and maturation
(Kimber et al., 1995; Jonuleit et al., 1996; Banchereau and Steinman, 1998).
In this work, we studied the effect of two strong contact sensitizers, DNFB and
NiSO4, on the expression of two membrane-associated receptors, CD40 and IL-12R,
in FSDC. The results show that both skin sensitizers upregulated the expression of
the two cell surface molecules, CD40 and IL-12R, whereas the non-sensitizer DCNB
had no significant effect (Figs. 1 and 2). In another set of experiments we tested the
effect of pre-incubating FSDC with GM-CSF, which induces FSDC maturation
(Kimber et al., 1995; Jonuleit et al., 1996; Pieri et al., 2001), on the response to the
Fig. 2. Effect of GM-CSF on NiSO4- and DNFB-induced IL-12R expression. (a) Western blot analysis of
IL-12Rb1 protein. FSDC cells (2 · 106 cells) were incubated in the absence (control, lane 1) or in the
presence of GM-CSF (100 ng/ml, lane 2), NiSO4 (50 lg/ml, lane 4) or DNFB (1 lg/ml, lane 5). Where
indicated, the cells were stimulated with GM-CSF in the presence of DNFB (1 lg/ml, lane 3) or NiSO4
(50 lg/ml, lane 6). Total cell extracts were electrophoresed through SDS-PAGE and subjected to western
blot analysis using an anti-IL-12Rb1 antibody, as described in materials and methods. The blot shown is
representative of three blots yielding similar results. The blot was digitally generated using a HP ScanJet
5p and processed in the Adobe Photoshop 7.0 program. (b) The bands were quantified with an image
analyser. The values are means ± SEM from three independent experiments, where *p < 0.05,
**p < 0.01 and ***p < 0.001, as determined by one-way ANOVA with Bonferroni’s multiple compar-
ison test. (c) Immunofluorescence analysis of IL-12R protein. FSDC cells (0.2 · 106 cells) were incubated
on a Lab Tek chamber with cover, under the same conditions as described in A. Immunostaining assay
was performed as described in materials and methods. Immunorreactivity means IL-12R protein
expression (% of control). Scale bars = 50 lm.
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sensitizers. The results show that GM-CSF alone slightly increased CD40 and IL-
12R expression, and this effect was additive with the result of cell stimulation only
with the allergens (Figs. 1 and 2).
The upregulation in the expression of CD40 observed here (Fig. 1) is in
agreement with the results obtained in other DCs (Coutant et al., 1999). CD40 is a
membrane-associated receptor belonging to the tumor necrosis factor-receptor
(TNF-R) family that is expressed broadly, including in DCs (van Kooten and
Banchereau, 2000). CD40 interacts with the CD40 ligand (CD40L) on naı¨ve T cells
in a process important for initiating primary immune responses (Banchereau et al.,
2000). CD40 activation by CD40L is critical for maintaining DC viability, to pro-
mote their maturation through the upregulation of costimulatory molecules and to
control their migration to the draining lymph nodes (Moodycliffe et al., 2000; Mann
et al., 2002). CD40 ligation also activates cytokine gene expression in DCs and
promotes IL-6 and IL-12 secretion, which is important in driving T cell development
and in the initiation of primary immune responses (Mann et al., 2002; Wesa and
Galy, 2002). Therefore, CD40 could be regarded as a surface marker of DC acti-
vation. In the present work we also found that DNFB induced a higher increase in
CD40 expression than NiSO4 (Fig. 1), which is in agreement with the in vitro and in
vivo stronger activity of this skin sensitizer (Yokozeki et al., 1995).
FSDC were cultured with GM-CSF in the absence or in the presence of the
contact sensitizers, in order to mimic the in vivo events. During CHS, epidermal
keratinocytes provide a wide range of cytokines that influence the differentiation of
cells of the dendritic lineage, in particular Langerhans cells. GM-CSF is one of these
cytokines, relevant for the maintenance of the differentiated state of LCs within
epidermis (Pieri et al., 2001). Also, a variety of environmental stimuli, including
epicutaneous contact with the skin sensitizers used in the present work, induce
epidermal keratinocytes to release inflammatory and chemotactic cytokines and
growth promoting cytokines, namely GM-CSF (Corsini and Galli, 1998). In fact,
our results show that GM-CSF alone slightly increased CD40 expression, a marker
of DC maturation, which is in agreement with a previous report showing that GM-
CSF slightly upregulated CD40 expression in purified LCs (Salgado et al., 1999). The
slightly higher CD40 upregulation in the presence of GM-CSF together with sen-
sitizers indicate that the effect of these two stimuli was additive. The gene that codes
for CD40 contains NF-jB binding sites in its enhancer promoter regions (Yo-
shimura et al., 2001; Nguyen and Benveniste, 2002), and this may constitute the
mechanism whereby CD40 protein levels are upregulated by allergens and by this
epidermal cytokine. Indeed, GM-CSF, NiSO4 and DNFB activate the NF-jB
transcription factor in FSDC (Cruz et al., 2001; Cruz et al., 2002; Vital et al., 2003).
NiSO4 induces the translocation of p65, RelB and cRel from the cytosol to the
nucleus, whereas GM-CSF induces the translocation of p50, p52 and RelB proteins
(Cruz et al., 2001; Cruz et al., 2002). The differential activation of NF-jB compo-
nents by GM-CSF and NiSO4 may explain the additive effect of GM-CSF and
NiSO4 on CD40 protein levels. In contrast, GM-CSF and DNFB activate the same
NF-jB elements, suggesting that the regulation of CD40 by the cytokine and the
allergen may involve additional signaling events.
The sensitizers DNFB and NiSO4 also increased the expression of IL-12R, as
shown in Fig. 2. In addition, GM-CSF upregulated this effect when was tested
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together with the sensitizers. The IL-12R complex is composed of two beta-type
cytokine receptor subunits, IL-12Rb1 and IL-12Rb2 (Presky et al., 1996; Nagayama
et al., 2000) and has been described in dendritic cells, T cells, NK cells and other
PBMC (Desai et al., 1992; Chua et al., 1994; Chua et al., 1995; Presky et al., 1996).
IL-12Rb1 mediates the signaling events induced by IL-12 on DCs, which promote
their functional activation (Grohmann et al., 1998; Nagayama et al., 2000). How-
ever, the effect of skin sensitizers on IL-12R expression had never been addressed
before.
Previous reports have shown that contact sensitizers like DNCB, which has a
similar sensitizing potential as DNFB, can induce IL-12p40 subunit production by
some APCs (Warbrick et al., 1999). Therefore, DC upregulation of IL-12R induced
by the sensitizers could be fundamental for the engagement of IL-12 produced by the
DC itself or by other cells in the vicinity, thus promoting IL-12 signaling and
functional DC activation. Accordingly, studies concerning the regulation of IL-12R
have shown that an increase in IL-12 production and release is sufficient to induce
expression of the two subunits of IL-12R, beta 1 and beta 2, by an autocrine
mechanism in T cells (Rogge et al., 1997; Kim et al., 2001). One of the signaling
pathways activated by IL-12 after binding to its receptor involves members of NF-
jB in DCs (Grohmann et al., 1998; Yoshimura et al., 2001) and, therefore, it is
possible that the expression of IL-12R is dependent on NF-jB. Since GM-CSF,
NiSO4 and DNFB also activates NF-jB in FSDC (Cruz et al., 2001; Cruz et al.,
2002; Vital et al., 2003), this may be the mechanism whereby the cytokine and the
sensitizers upregulate IL-12R protein levels in the cells.
IL-12 is a pivotal cytokine during antigen presentation, inducing functional
activation of DCs, by the upregulation of the expression of MHC-II molecules
(Grohmann U et al., 1998; Kelleher and Knight, 1998; Nagayama et al., 2000) and
the secretion of several cytokines, namely GM-CSF, IL-1b, IL-6, TNF-a, IFN-c and
IL-12p40 subunit itself (Grohmann et al., 1998; Kelleher and Knight, 1998; Na-
gayama et al., 2000). Since haptens induce IL-12 production by antigen presenting
cells, namely DCs (Warbrick et al., 1999), the upregulation of IL-12R in FSDC
reported here suggests that the sensitizers cause a general upregulation of IL-12
function. This also suggests that IL-12 may play a key role in the response of DCs to
the presence of the sensitizers.
In summary, we observed that the two skin contact sensitizers, DNFB and
NiSO4, increased FSDC expression of the two membrane-associated receptors,
CD40 and IL-12R, whereas the non-sensitizer DCNB had no significant effect as
expected. GM-CSF also increased in a small extent the expression of both proteins,
and this effect was additive with the effect of the allergens. These results suggest that
these skin contact sensitizers induced early specific phenotype changes that may
represent an early-activation state of the DCs, which could be responsible for the
initiation of the sensitization phase of CHS in vivo. In addition, these results also
suggest that the epidermal cytokine GM-CSF is involved on these changes. More-
over, we interestingly observed that the higher expression of CD40 and IL-12R was
obtained with the stronger sensitizer DNFB, whereas NiSO4 induced a lower
expression of those proteins. Our results suggest that upregulation of CD40 and
IL-12R expression could also be a promising readout in prescreening for strong and
moderate contact sensitizers and could help to develop an in vitro assay to reduce the
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number of experimental animals used for ascertaining the sensitizing potential of
environmental chemicals.
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